Vinpocetine

Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta: H.S. Ahn, et al.; Biochem. Pharmacol. 38, 3331 (1989) | Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine: J.E. Souness, et al.; Br. J. Pharmacol. 98, 725 (1989) | Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation: M. Sitges & V. Nekrassov; Neurochem. Res. 24, 1585 (1999) | In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine: B. Horvath, et al.; Clin. Neuropharmacol. 25, 37 (2002) | Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons: K. Tarnok, et al.; Neurochem. Int. 53, 289 (2008) | Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor: R. Deshmukh, et al.; Eur. J. Pharmacol. 620, 49 (2009) | Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism: K.I. Jeon, et al.; PNAS 107, 9795 (2010) | Vinpocetine as a potent antiinflammatory agent: A.E. Medina, et al.; PNAS 107, 9921 (2010) | Vinpocetine inhibits breast cancer cells growth in vitro and in vivo: E.W. Huang, et al.; Apoptosis 17, 1120 (2012) | Vinpocetine attenuates lipid accumulation and atherosclerosis formation: Y. Cai, et al.; BBRC 434, 439 (2013) | The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1beta and TNF-alpha expression in rat hippocampus: C.D. Gomez, et al.; J. Neurochem. 130, 770 (2014) | Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature: L. Zhang & L. Yang; Molecules 20, 335 (2014) | Vinpocetine inhibits amyloid-beta induced activation of NF-kappaB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells: R.T. Liu, et al.; Exp. Eye Res. 127, 49 (2014) | Vinpocetine modulates metabolic activity and function during retinal ischemia: L. Nivison-Smith, et al.; Am. J. Physiol. Cell Physiol. 308, 737 (2015) | Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-kappaB: K.W. Ruiz-Miyazawa, et al.; Chem. Biol. Interact. 237, 9 (2015) | Vinpocetine attenuates osteoblastic differentiation of vascular smooth muscle cells: Y.Y. Ma, et al.; PLoS One 11, e0162295 (2016) | A comparative study on the anti-schistosomal and hepatoprotective effects of vinpocetine and isosorbide-5-mononitrate on Schistosoma mansoni-infected mice: S.M. Alhusseiny, et al.; Acta Tropica 176, 114 (2017) | Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation: I.O. Ishola, et al.; Metab. Brain Dis. 35, 1493 (2018) | The reduction of XIAP is associated with inflammasome activation in RPE: implications for AMD pathogenesis: J. Gao, et al.; J. Neuroinflamm. 16, 171 (2019) | Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats: A.E. Elnfarawy, et al. Hum. Exp. Toxicol. ahead of print, 2020 | Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases: Ch. Zhang & Ch. Yan; J. Cell Immunol. 2, 211 (2020) (Review) | Vinpocetine protects against the development of experimental abdominal aortic aneurysms: Ch. Zhang, et al.; Clin. Sci. 134, 2959 (2020)